Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/43405
Title: Fluorescent TEM-1 β-lactamase with wild-type activity as a rapid drug sensor for in vitro drug screening
Authors: Cheong, WL
Tsang, MS
So, PK
Chung, WH
Leung, YC 
Chan, PH 
Keywords: Antibiotics
Bacteria
Drug screening
Inhibitors sensor
β-lactamase
Issue Date: 2014
Publisher: Portland Press
Source: Bioscience reports, 2014, v. 34, no. 5, e00136, p. 523-533 How to cite?
Journal: Bioscience reports 
Abstract: We report the development of a novel fluorescent drug sensor from the bacterial drug target TEM-1 β-lactamase through the combined strategy of Val216→Cys216 mutation and fluorophore labelling for in vitro drug screening. The Val216 residue in TEM-1 is replaced with a cysteine residue, and the environment-sensitive fluorophore fluorescein-5-maleimide is specifically attached to the Cys216 residue in the V216C mutant for sensing drug binding at the active site. The labelled V216C mutant has wild-type catalytic activity and gives stronger fluorescence when β-lactam antibiotics bind to the active site. The labelled V216C mutant can differentiate between potent and impotent β-lactam antibiotics and can distinguish active-site binders from non-binders (including aggregates formed by small molecules in aqueous solution) by giving characteristic time-course fluorescence profiles. Mass spectrometric, molecular modelling and trypsin digestion results indicate that drug binding at the active site is likely to cause the fluorescein label to stay away from the active site and experience weaker fluorescence quenching by the residues around the active site, thus making the labelled V216C mutant to give stronger fluorescence in the drug-bound state. Given the ancestor's role of TEM-1 in the TEM family, the fluorescent TEM-1 drug sensor represents a good model to demonstrate the general combined strategy of Val216→Cys216 mutation and fluorophore labelling for fabricating tailor-made fluorescent drug sensors from other clinically significant TEM-type β-lactamase variants for in vitro drug screening.
URI: http://hdl.handle.net/10397/43405
ISSN: 0144-8463
DOI: 10.1042/BSR20140057
Appears in Collections:Journal/Magazine Article

Access
View full-text via PolyU eLinks SFX Query
Show full item record

SCOPUSTM   
Citations

1
Last Week
0
Last month
Citations as of Mar 17, 2017

WEB OF SCIENCETM
Citations

1
Last Week
0
Last month
Citations as of Mar 19, 2017

Page view(s)

12
Last Week
3
Last month
Checked on Mar 19, 2017

Google ScholarTM

Check

Altmetric



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.